XML 37 R8.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Segment Information
6 Months Ended
Jun. 30, 2012
Business segment information[Abstract]  
Business segment information

Note 2 – Business segment information:

 

             

Business segment

 

Entity

  % controlled at
June 30, 2012
 
Chemicals   Kronos     80
Component products   CompX     87
Waste management   WCS     100

Our control of Kronos includes 50% we hold directly and 30% held directly by NL. We own 83% of NL. Our control of CompX is through NL.

 

                                 
    Three months ended
June  30,
    Six months ended
June 30,
 
    2011     2012     2011     2012  
    (In millions)  

Net sales:

                               

Chemicals

  $ 537.6     $ 545.3     $ 958.0     $ 1,106.6  

Component products

    35.2       37.6       70.0       73.1  

Waste management

    .3       .9       .8       2.0  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total net sales

  $ 573.1     $ 583.8     $ 1,028.8     $ 1,181.7  
   

 

 

   

 

 

   

 

 

   

 

 

 

Cost of sales:

                               

Chemicals

  $ 341.2     $ 382.6     $ 615.8     $ 683.0  

Component products

    25.4       27.6       51.5       53.6  

Waste management

    5.8       8.1       11.9       15.7  
   

 

 

   

 

 

   

 

 

   

 

 

 

Total cost of sales

  $ 372.4     $ 418.3     $ 679.2     $ 752.3  
   

 

 

   

 

 

   

 

 

   

 

 

 

Gross margin:

                               

Chemicals

  $ 196.4     $ 162.7     $ 342.2     $ 423.6  

Component products

    9.8       10.0       18.5       19.5  

Waste management

    (5.5     (7.2     (11.1     (13.7
   

 

 

   

 

 

   

 

 

   

 

 

 

Total gross margin

  $ 200.7     $ 165.5     $ 349.6     $ 429.4  
   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income (loss):

                               

Chemicals

  $ 145.9     $ 112.4     $ 249.4     $ 323.7  

Component products

    3.1       3.9       11.9       6.8  

Waste management

    (9.2     (11.3     (18.2     (20.9
   

 

 

   

 

 

   

 

 

   

 

 

 

Total operating income

    139.8       105.0       243.1       309.6  

Equity in earnings of investee

    (.1     (.1     (.2     —    

General corporate items:

                               

Securities earnings

    7.4       7.1       14.8       14.2  

Insurance recoveries

    .1       .3       .5       1.4  

Litigation settlement gain

    —         14.7       —         14.7  

General expenses, net

    (16.8     (9.2     (23.4     (29.5

Loss on prepayment of debt

    —         (7.2     (3.3     (7.2

Interest expense

    (15.9     (14.4     (33.1     (27.9
   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

  $ 114.5     $ 96.2     $ 198.4     $ 275.3  
   

 

 

   

 

 

   

 

 

   

 

 

 

 

Segment results we report may differ from amounts separately reported by our various subsidiaries and affiliates due to purchase accounting adjustments and related amortization or differences in the way we define operating income. Intersegment sales are not material. We received approximately $7.5 million for a patent litigation settlement in the first quarter of 2011, which is included in the determination of Component Products operating income, see Note 11.